Dr. Michael Mithoefer



Michael Mithoefer, M.D., began collaborating with MAPS in 2000 on the first U.S. Phase 2 clinical trial of MDMA-assisted  psychotherapy.

He has since conducted two of the six MAPS-sponsored Phase 2 clinical trials testing MDMA-Assisted Psychotherapy for PTSD, as well a study providing MDMA-assisted  sessions for therapists who have completed the MAPS-sponsored  MDMA Therapy Training Program, and a pilot study treating couples  with MDMA-Assisted Psychotherapy combined with Cognitive-Behavioural Conjoint Therapy.

He is now Senior Medical Director for  Medical Affairs, Training and Supervision at MAPS Public Benefit Corporation (MAPS PBC). He is a Grof-certified Holotropic Breathwork Facilitator, is trained in EMDR and Internal Family Systems Therapy, and has nearly 30 years of experience treating trauma patients.

Sign Up for Newsletter


Awakn Life Sciences Corp.
301-217 Queen St. W
Toronto, Ontario M5V 0R2

© 2023 Awakn Life Sciences Corp      |      Privacy Policy      |      Disclaimer

Back to top Arrow